![Hartoun Hartounian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hartoun Hartounian
Directeur des opérations chez BRAINSTORM CELL THERAPEUTICS INC.
Fortune : 14 610 $ au 31/05/2024
Postes actifs de Hartoun Hartounian
Sociétés | Poste | Début | Fin |
---|---|---|---|
BRAINSTORM CELL THERAPEUTICS INC. | Directeur des opérations | 24/06/2024 | - |
San Diego Tech Coast Angels | Corporate Officer/Principal | - | - |
Historique de carrière de Hartoun Hartounian
Anciens postes connus de Hartoun Hartounian
Sociétés | Poste | Début | Fin |
---|---|---|---|
Highlander Factory, Inc.
![]() Highlander Factory, Inc. BiotechnologyHealth Technology Highlander Factory, Inc. engages in development and manufacture of cell and gene therapy. The company was founded by Haro Hartounian in 2019 and is headquartered in Newark, NJ. | Directeur/Membre du Conseil | 01/05/2022 | 01/12/2023 |
Directeur Général | 01/05/2022 | 01/12/2023 | |
Fondateur | 01/05/2022 | 01/12/2023 | |
President | 01/05/2022 | 01/12/2023 | |
Vyteris, Inc.
![]() Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Directeur/Membre du Conseil | 09/08/2011 | 09/08/2011 |
President | - | 09/08/2011 | |
MicroIslet, Inc.
![]() MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 17/02/2006 | 17/02/2006 |
Directeur des opérations | 17/02/2006 | 17/02/2006 | |
President | - | 17/02/2006 | |
MONSANTO | Corporate Officer/Principal | 01/01/1998 | 01/01/2001 |
PROTAGENIC THERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/02/1994 | - |
Fondateur | 03/02/1994 | - | |
Protagenic Therapeutics, Inc. /Old/
![]() Protagenic Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY. | Directeur/Membre du Conseil | 15/09/2009 | - |
Drexel University | Corporate Officer/Principal | 15/09/2009 | - |
Formation de Hartoun Hartounian
University of Delaware | Doctorate Degree |
University of California, Los Angeles | Graduate Degree |
Sharif University of Technology | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 12 |
Iran | 2 |
Opérationnelle
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
President | 3 |
Sectorielle
Health Technology | 6 |
Consumer Services | 5 |
Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
PROTAGENIC THERAPEUTICS, INC. | Health Technology |
BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Monsanto Co.
![]() Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
Protagenic Therapeutics, Inc. /Old/
![]() Protagenic Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY. | Health Technology |
MicroIslet, Inc.
![]() MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | Commercial Services |
San Diego Tech Coast Angels | |
Vyteris, Inc.
![]() Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Health Technology |
Highlander Factory, Inc.
![]() Highlander Factory, Inc. BiotechnologyHealth Technology Highlander Factory, Inc. engages in development and manufacture of cell and gene therapy. The company was founded by Haro Hartounian in 2019 and is headquartered in Newark, NJ. | Health Technology |
- Bourse
- Insiders
- Hartoun Hartounian
- Expérience